Answers are grounded in this paper and cite their sources.
Home-based 12-lead ECGs are feasible and could enhance screening and follow-up for cardiac diseases.
In the editorial ‘Is it time for a consumerized or home-based 12-lead electrocardiogram?’, Tooley and Turakhia1 pointed out the important limitations of one-lead electrocardiogram (ECG) or multi-lead ECG without precordial leads. They called for home based 12-lead ECG because ‘The hospital 12-lead ECG remains too cumbersome, and adapting a single left arm-right arm smartwatch ECG to obtain additional vectors is not ideal due to the high potential for baseline artefact and user error.’ I agree with the authors that ‘We need “quick and easy” 12-lead ECG systems—not just for the consumer, but for a pre-hospital, emergency, inpatient, and outpatient care.’ In a study of 12-lead ECG performed at home by patients with no training or experience, it was shown that over 92% patients completed their tests successfully, and technical failure was <2%.2 I believe 12-lead ECG will soon join blood pressure, pulse oximetry, glucose, and one-lead ECG to be a test that we offer to patients to do at home. Home-based 12-lead ECG will greatly enhance the capability of screening diseases in silent state, early detection of subtle clinical changes, and follow up of patients with symptomatic diseases.
No takes yet. Share an insight, caveat, or question.
Ruey‐Kang R. Chang (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: